Vascular risk factors in glaucoma: A review

Clinical and Experimental Ophthalmology

Volumn 39, Issue 3, 2011, Pages 252-258

  Yanagi, Masahide ^a,b   Kawasaki, Ryo ^a   Wang, Jie Jin ^a,c   Wong, Tien Y ^a,d   Crowston, Jonathan ^a   Kiuchi, Yoshiaki ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF SYDNEY   (Australia)

^d NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Ocular blood flow; Ocular perfusion pressure; Retinal ganglion cell; Retinal vascular calibre

Indexed keywords

AGING; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; DIABETES MELLITUS; EYE BLOOD FLOW; GLAUCOMA; HUMAN; HYPERTENSION; PATHOGENESIS; REVIEW; RISK FACTOR; SMOKING; THEORY;

BLOOD FLOW VELOCITY; BLOOD PRESSURE; EYE; GLAUCOMA, OPEN-ANGLE; HUMANS; INTRAOCULAR PRESSURE; REGIONAL BLOOD FLOW; RISK FACTORS;

EID: 79953050041     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2010.02455.x     Document Type: Review

References (67)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80: 389-93.
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90: 262-7.
3. Gupta N, Weinreb RN. New definitions of glaucoma. Curr Opin Ophthalmol 1997; 8: 38-41.
4. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989; 107: 453-64.
5. Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in primary open angle glaucoma. Surv Ophthalmol 1994; 39: 23-42.
6. Kass MA, Heuer DK, Higginbotham EJ etal. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120: 701-13, discussion 829-30.
7. Flammer J, Orgul S, Costa VP etal. The impact of ocular blood flow in glaucoma. Prog Retin Eye Res 2002; 21: 359-93.
8. Minckler DS, Tso MO. A light microscopic, autoradiographic study of axoplasmic transport in the normal rhesus optic nerve head. Am J Ophthalmol 1976; 82: 1-15.
9. Farkas RH, Grosskreutz CL. Apoptosis, neuroprotection, and retinal ganglion cell death: an overview. Int Ophthalmol Clin 2001; 41: 111-30.
10. Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol 2007; 52(Suppl. 2): S162-73.
11. He P, Zhang H, Zhu L, Jiang Y, Zhou X. Leukocyte-platelet aggregate adhesion and vascular permeability in intact microvessels: role of activated endothelial cells. Am J Physiol Heart Circ Physiol 2006; 291: H591-9.
12. [No authors listed]. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol 1998; 126: 487-97.
13. Flammer J. The vascular concept of glaucoma. Surv Ophthalmol 1994; 38(Suppl.): S3-6.
14. Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC. Hypertension, perfusion pressure, and primary open-angle glaucoma. A population-based assessment. Arch Ophthalmol 1995; 113: 216-21.
15. Drance SM, Douglas GR, Wijsman K, Schulzer M, Britton RJ. Response of blood flow to warm and cold in normal and low-tension glaucoma patients. Am J Ophthalmol 1988; 105: 35-9.
16. Mitchell P, Smith W, Chey T, Henley PR. Open-angle glaucoma and diabetes - the Blue Mountains Eye Study, Australia. Ophthalmology 1997; 104: 712-18.
17. Satilmis M, Orgul S, Doubler B, Flammer J. Rate of progression of glaucoma correlates with retrobulbar circulation and intraocular pressure. Am J Ophthalmol 2003; 135: 664-9.
18. Cheung W, Guo L, Cordeiro MF. Neuroprotection in glaucoma: drug-based approaches. Optom Vis Sci 2008; 85: 406-16.
19. Ko ML, Peng PH, Ma MC, Ritch R, Chen CF. Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic Biol Med 2005; 39: 365-73.
20. Moenkemann H, Flammer J, Wunderlich K, Breipohl W, Schild HH, Golubnitschaja O. Increased DNA breaks and up-regulation of both G(1) and G(2) checkpoint genes p21(WAF1/CIP1) and 14-3-3 sigma in circulating leukocytes of glaucoma patients and vasospastic individuals. Amino Acids 2005; 28: 199-205.
21. Emre M, Orgul S, Haufschild T, Shaw SG, Flammer J. Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma. Br J Ophthalmol 2005; 89: 60-3.
22. Tomita G, Yamada T, Matsubara K, Kitazawa Y. Glaucoma-like disc without increased intraocular pressure or visual field loss and early stage normal-tension glaucoma disc. Nippon Ganka Gakkai Zasshi 1993; 97: 225-31.
23. Mitchell P, Leung H, Wang JJ etal. Retinal vessel diameter and open-angle glaucoma: the Blue Mountains Eye Study. Ophthalmology 2005; 112: 245-50.
24. Amerasinghe N, Aung T, Cheung N etal. Evidence of retinal vascular narrowing in glaucomatous eyes in an Asian population. Invest Ophthalmol Vis Sci 2008; 49: 5397-402.
25. Chopra V, Varma R, Francis BA, Wu J, Torres M, Azen SP. Type 2 diabetes mellitus and the risk of open-angle glaucoma the Los Angeles Latino Eye Study. Ophthalmology 2008; 115: 227-32. e1.
26. Nakamura M, Kanamori A, Negi A. Diabetes mellitus as a risk factor for glaucomatous optic neuropathy. Ophthalmologica 2005; 219: 1-10.
27. Sato T, Roy S. Effect of high glucose on fibronectin expression and cell proliferation in trabecular meshwork cells. Invest Ophthalmol Vis Sci 2002; 43: 170-5.
28. Oh SW, Lee S, Park C, Kim DJ. Elevated intraocular pressure is associated with insulin resistance and metabolic syndrome. Diabetes Metab Res Rev 2005; 21: 434-40.
29. Klein BE, Klein R, Jensen SC. Open-angle glaucoma and older-onset diabetes. The Beaver Dam Eye Study. Ophthalmology 1994; 101: 1173-7.
30. Ellis JD, Evans JM, Ruta DA etal. Glaucoma incidence in an unselected cohort of diabetic patients: is diabetes mellitus a risk factor for glaucoma? DARTS/MEMO collaboration. Diabetes Audit and Research in Tayside Study. Medicines Monitoring Unit. Br J Ophthalmol 2000; 84: 1218-24.
31. Tielsch JM, Katz J, Quigley HA, Javitt JC, Sommer A. Diabetes, intraocular pressure, and primary open-angle glaucoma in the Baltimore Eye Survey. Ophthalmology 1995; 102: 48-53.
32. Mitchell P, Lee AJ, Rochtchina E, Wang JJ. Open-angle glaucoma and systemic hypertension: the blue mountains eye study. J Glaucoma 2004; 13: 319-26.
33. Ulrich A, Ulrich C, Barth T, Ulrich WD. Detection of disturbed autoregulation of the peripapillary choroid in primary open angle glaucoma. Ophthalmic Surg Lasers 1996; 27: 746-57.
34. Leske MC, Wu SY, Hennis A, Honkanen R, Nemesure B. Risk factors for incident open-angle glaucoma: the Barbados Eye Studies. Ophthalmology 2008; 115: 85-93.
35. Demailly P, Cambien F, Plouin PF, Baron P, Chevallier B. Do patients with low tension glaucoma have particular cardiovascular characteristics? Ophthalmologica 1984; 188: 65-75.
36. Kaiser HJ, Flammer J, Graf T, Stumpfig D. Systemic blood pressure in glaucoma patients. Graefes Arch Clin Exp Ophthalmol 1993; 231: 677-80.
37. Weinreb RN, Harris A. Ocular Blood Flow in Glaucoma. Amsterdam: Kugler Publications, 2009.
38. Li G, Luna C, Liton PB, Navarro I, Epstein DL, Gonzalez P. Sustained stress response after oxidative stress in trabecular meshwork cells. Mol Vis 2007; 13: 2282-8.
39. Edwards R, Thornton J, Ajit R, Harrison RA, Kelly SP. Cigarette smoking and primary open angle glaucoma: a systematic review. J Glaucoma 2008; 17: 558-66.
40. Fan BJ, Leung YF, Wang N etal. Genetic and environmental risk factors for primary open-angle glaucoma. Chin Med J (Engl) 2004; 117: 706-10.
41. Wilson MR, Hertzmark E, Walker AM, Childs-Shaw K, Epstein DL. A case-control study of risk factors in open angle glaucoma. Arch Ophthalmol 1987; 105: 1066-71.
42. Klein BE, Klein R, Ritter LL. Relationship of drinking alcohol and smoking to prevalence of open-angle glaucoma. The Beaver Dam Eye Study. Ophthalmology 1993; 100: 1609-13.
43. Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R. The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol 2001; 119: 1819-26.
44. Behrendt D, Ganz P. Endothelial function. From vascular biology to clinical applications. Am J Cardiol 2002; 90: 40L-8L.
45. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26.
46. de Voogd S, Wolfs RC, Jansonius NM, Witteman JC, Hofman A, de Jong PT. Atherosclerosis, C-reactive protein, and risk for open-angle glaucoma: the Rotterdam study. Invest Ophthalmol Vis Sci 2006; 47: 3772-6.
47. Moore D, Harris A, Wudunn D, Kheradiya N, Siesky B. Dysfunctional regulation of ocular blood flow: a risk factor for glaucoma? Clin Ophthalmol 2008; 2: 849-61.
48. Tan GS, Wong TY, Fong CW, Aung T. Diabetes, metabolic abnormalities, and glaucoma. Arch Ophthalmol 2009; 127: 1354-61.
49. Tanaka C, Yamazaki Y, Yokoyama H. Study on the progression of visual field defect and clinical factors in normal-tension glaucoma. Jpn J Ophthalmol 2001; 45: 117.
50. Kahn HA, Milton RC. Alternative definitions of open-angle glaucoma. Effect on prevalence and associations in the Framingham eye study. Arch Ophthalmol 1980; 98: 2172-7.
51. Schoff EO, Hattenhauer MG, Ing HH etal. Estimated incidence of open-angle glaucoma in Olmsted County, Minnesota. Ophthalmology 2001; 108: 882-6.
52. Harris A, Jonescu-Cuypers C, Martin B, Kagemann L, Zalish M, Garzozi HJ. Simultaneous management of blood flow and IOP in glaucoma. Acta Ophthalmol Scand 2001; 79: 336-41.
53. Burgoyne CF, Downs JC, Bellezza AJ, Suh JK, Hart RT. The optic nerve head as a biomechanical structure: a new paradigm for understanding the role of IOP-related stress and strain in the pathophysiology of glaucomatous optic nerve head damage. Prog Retin Eye Res 2005; 24: 39-73.
54. Kong GY, Van Bergen NJ, Trounce IA, Crowston JG. Mitochondrial dysfunction and glaucoma. J Glaucoma 2009; 18: 93-100.
55. Nicolela MT, Walman BE, Buckley AR, Drance SM. Ocular hypertension and primary open-angle glaucoma: a comparative study of their retrobulbar blood flow velocity. J Glaucoma 1996; 5: 308-10.
56. Akarsu C, Bilgili MY. Color Doppler imaging in ocular hypertension and open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol 2004; 242: 125-9.
57. Nagata A, Mishima H, Choshi K, Shimada S, Furumoto Y. [Fluorescein fundus angiography of optic nerve head in primary open angle glaucoma and low tension glaucoma]. Nippon Ganka Gakkai Zasshi 1992; 96: 1423-8.
58. Harwerth RS, Quigley HA. Visual field defects and retinal ganglion cell losses in patients with glaucoma. Arch Ophthalmol 2006; 124: 853-9.
59. Hayreh SS. Blood flow in the optic nerve head and factors that may influence it. Prog Retin Eye Res 2001; 20: 595-624.
60. Caprioli J, Coleman AL. Blood pressure, perfusion pressure, and glaucoma. Am J Ophthalmol 2010; 149: 704-12.
61. Punjabi OS, Stamper RL, Bostrom AG, Lin SC. Does treated systemic hypertension affect progression of optic nerve damage in glaucoma suspects? Curr Eye Res 2007; 32: 153-60.
62. Hulsman CA, Vingerling JR, Hofman A, Witteman JC, de Jong PT. Blood pressure, arterial stiffness, and open-angle glaucoma: the Rotterdam study. Arch Ophthalmol 2007; 125: 805-12.
63. Zheng Y, Wong TY, Mitchell P. Distribution of ocular perfusion pressure and its relationship with open angle glaucoma: the singapore malay eye study. Invest Ophthalmol Vis Sci 2010; 51: 3399-404.
64. Klein R, Klein BE, Tomany SC, Wong TY. The relation of retinal microvascular characteristics to age-related eye disease: the Beaver Dam eye study. Am J Ophthalmol 2004; 137: 435-44.
65. Wang S, Xu L, Wang Y, Jonas JB. Retinal vessel diameter in normal and glaucomatous eyes: the Beijing eye study. Clin Experiment Ophthalmol 2007; 35: 800-7.
66. Ikram MK, de Voogd S, Wolfs RC etal. Retinal vessel diameters and incident open-angle glaucoma and optic disc changes: the Rotterdam study. Invest Ophthalmol Vis Sci 2005; 46: 1182-7.
67. Iwase A, Suzuki Y, Araie M etal. The prevalence of primary open-angle glaucoma in Japanese: the Tajimi Study. Ophthalmology 2004; 111: 1641-8.